HYPR

SEC source: 0001209191-23-036341 · doc4.xml · derivative · entry 2

Wolterman Dan · CIK 0001586330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2023-06-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Mr. Wolterman's continued service through the applicable vesting date.

SEC source: 0001209191-23-036341 · doc4.xml · derivative · entry 1

Wolterman Dan · CIK 0001586330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Class A Common Stock · 112,000 shares

Expires 2033-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

SEC source: 0001209191-23-040603 · doc4a.xml · derivative · entry 2

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2033-06-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Ms. Fattori's continued service through the applicable vesting date.

SEC source: 0001209191-23-040603 · doc4a.xml · derivative · entry 1

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Class A Common Stock · 112,000 shares

Expires 2033-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

SEC source: 0001209191-23-040601 · doc4a.xml · derivative · entry 2

Wolterman Dan · CIK 0001586330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2033-06-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Mr. Wolterman's continued service through the applicable vesting date.

SEC source: 0001209191-23-040601 · doc4a.xml · derivative · entry 1

Wolterman Dan · CIK 0001586330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Class A Common Stock · 112,000 shares

Expires 2033-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

SEC source: 0000899243-23-013890 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2033-05-23

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% of the shares on May 23, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-23-029926 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,710

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-23-023896 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,400

Underlying: Class A Common Stock · 368,400 shares

Expires 2033-03-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% of the shares on March 3, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-23-010632 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,445

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-23-010623 · doc4.xml · nonDerivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,456

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-23-009721 · doc4.xml · derivative · entry 1

HALE BRETT · CIK 0001965293 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Class A Common Stock · 1,000,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 15, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Hale's continued service through the applicable vesting date.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 9

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F7 · kind: Sponsor distributed these shares to its members on a pro rata basis for no consideration.

F1 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

F8 · ownership.direct: A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly.

SEC source: 0001209191-22-061247 · doc4.xml · nonDerivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,425

SEC source: 0001209191-22-060775 · doc4a.xml · nonDerivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,425

SEC source: 0001209191-22-060673 · doc4.xml · nonDerivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,425

SEC source: 0001209191-22-060389 · doc4.xml · nonDerivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,161

SEC source: 0001209191-22-060774 · doc4a.xml · nonDerivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,161

SEC source: 0001209191-22-059008 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 885,707

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-058979 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 656,492

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.69 to $0.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-057388 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,080

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-057386 · doc4.xml · nonDerivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,172

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-057383 · doc4.xml · nonDerivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,069

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-057117 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,485

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.92 to $0.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-056870 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578,346

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 10

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F5 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 9

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F5 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 8

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 7

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 6

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,796

Underlying: Class A Common Stock · 1,796 shares

Expires 2031-05-12

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 5

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,796 shares

Expires 2031-05-12

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 4

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,037

Underlying: Class A Common Stock · 54,037 shares

Expires 2031-04-14

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 3

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 54,037 shares

Expires 2031-04-14

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 2

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,145

Underlying: Class A Common Stock · 235,145 shares

Expires 2030-01-27

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 235,145 shares

Expires 2030-01-27

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 6

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,250

Underlying: Class A Common Stock · 98,250 shares

Expires 2031-04-27

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 5

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 98,250 shares

Expires 2031-04-27

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 4

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2032-02-09

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 3

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 85,000 shares

Expires 2032-02-09

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 2

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,750

Underlying: Class A Common Stock · 71,750 shares

Expires 2032-02-09

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

SEC source: 0001209191-22-055109 · doc4.xml · derivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 71,750 shares

Expires 2032-02-09

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

SEC source: 0001209191-22-055111 · doc4.xml · derivative · entry 4

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,333

Underlying: Class A Common Stock · 54,333 shares

Expires 2032-02-09

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001209191-22-055111 · doc4.xml · derivative · entry 3

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 54,333 shares

Expires 2032-02-09

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001209191-22-055111 · doc4.xml · derivative · entry 2

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Class A Common Stock · 200,000 shares

Expires 2032-02-09

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

SEC source: 0001209191-22-055111 · doc4.xml · derivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 200,000 shares

Expires 2032-02-09

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 58,333 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Gupta's continued service on each vesting date.

SEC source: 0001209191-22-055102 · doc4.xml · derivative · entry 1

Sainz Maria · CIK 0001437768 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,175,000

Underlying: Class A Common Stock · 3,175,000 shares

Expires 2032-10-24

F1 · price: The shares underlying this option vest as to 25% on October 24, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date.

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on October 24, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date.

SEC source: 0001209191-22-055104 · doc4.xml · derivative · entry 2

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2032-03-08

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

SEC source: 0001209191-22-055104 · doc4.xml · derivative · entry 1

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 100,000 shares

Expires 2032-03-08

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 8, 2022, and is fully vested.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 8

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,437

Underlying: Class A Common Stock · 237,437 shares

Expires 2031-04-27

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021.

F5 · price: The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).

F5 · derivative.exercise_date: The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 7

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 237,437 shares

Expires 2031-04-27

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021.

F5 · price: The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).

F5 · derivative.exercise_date: The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).